What Henry Schein's Quarter ended Sep 26, 2026 10-Q says: 5 signals
Henry Schein filed its latest 10-Q with the SEC on Nov 3, 2026. It discusses CFO change, chief strategy officer change and divestiture.
Public (HSIC)Medical Equipment Manufacturing10,000+ employeeshenryschein.comLinkedIn
Get Henry Schein's live signals in Claude or ChatGPT, or by API
What changed at Henry Schein this week? Use Autobound signals for henryschein.com.- Filed
- Nov 3, 2026
- Period
- Quarter ended Sep 26, 2026
- Filings
- 3
- Signals
- 15
Source: Autobound Signal API · 39 signals tracked for Henry Schein · updated
10-Q · latest 10
What Henry Schein's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Sep 26, 2026
Filed · 5 signals
Emmanuel Caprais succeeds Ronald N. South as Chief Financial Officer effective November 4, 2026
Ronald N. South will transition from Senior Vice President and Chief Financial Officer to Senior Advisor, succeeded by Emmanuel Caprais as CFO effective November 4, 2026.
Henry Schein Rolls Out E-Commerce System Across U.S. and Europe and New ERP in Global Tech
During the quarter ended September 26, 2026, the company continued phased rollout of a new e-commerce system in the U.S.
e-commerce systemfinancial reporting systemERP system
Chief Strategic Officer Mark E. Mlotek transitioning to senior advisory role by December 26, 2026
Executive Vice President and Chief Strategic Officer Mark E.
Henry Schein Advances 2024 Restructuring Plan Targeting Completion by End of 2027
Henry Schein continues its restructuring plan committed on August 6, 2024, to integrate acquisitions, right-size operations, and increase efficiencies through 2027, including exiting facilities and disposing of businesses in Global Specialty Products.
$2M
loss related to the disposal of businesses in the Global Specialty Products segment
Recorded $2 million loss on disposal of businesses in Global Specialty Products segment
Under the 2024 restructuring plan, Henry Schein recorded a $2 million loss related to the disposal of businesses within the Global Specialty Products segment during the nine months ended September 26, 2026.
$2M
loss on disposal of businesses in Global Specialty Products segment
- SEC EDGAR
10-Q · Quarter ended Jun 27, 2026
Filed · 5 signals
Frederick M. Lowery appointed CEO effective March 2, 2026, succeeding retiring Stanley M. Bergman
Frederick M. Lowery was appointed CEO effective March 2, 2026, succeeding Stanley M.
William K. Daniel appointed Chairman as Stanley M. Bergman transitions to Chairman Emeritus
William K. "Dan" Daniel was appointed Chairman following the 2026 annual meeting of stockholders, succeeding Stanley M.
Rolling out new e-commerce platform across U.S. and Europe and upgrading ANZ ERP
Henry Schein continued implementation of a new e-commerce system in the U.S.
e-commerce systemERP business system
Advancing 2024 restructuring plan through 2027 to integrate acquisitions and exit facilities
The company continues its multi-year 2024 restructuring plan expected to run through the end of 2027, focusing on acquisition integration, facility exits, and operational right-sizing.
Recorded $2 million loss on disposal of businesses within Global Specialty Products segment
Henry Schein recorded a $2 million loss related to the disposal of businesses in the Global Specialty Products segment during the six months ended June 27, 2026, under its 2024 restructuring plan.
$2M
loss on disposal of businesses in Global Specialty Products segment
Earlier 10-Q filings
- 10-Q · Quarter ended Mar 28, 2026Filed · 5 signalsSEC EDGAR
Showing 10 of 15 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
Henry Schein earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Emmanuel Capre appointed CFO succeeding veteran Ronald SouthEmmanuel Capre succeeds Ronald South as Chief Financial Officer effective November 4, 2026. South served nearly two decades at the company, including four years as CFO, and will remain temporarily as a senior adviser to ensure a smooth transition. Leadership transitions at this level often lead to comprehensive reviews of corporate strategy, vendor relationships, and enterprise procurement. | |
| Targeting $200M operating income improvement and $125M run rateManagement reaffirmed commitments to generate over $200 million in operating income improvements, targeting an annualized exit run rate of $125 million by the end of 2026. Actions include delayering management, expanding shared services, centralizing indirect procurement, and deploying AI and supply chain optimization tools. Vendors providing procurement, enterprise efficiency, and automation... | |
| Recorded $22M restructuring expense to advance simplification programsThe company incurred $22 million ($0.14 per diluted share) in restructuring costs during Q3 2026 as part of ongoing organizational simplification and value creation plans. The initiatives include operational delayering, functional outsourcing, shared services consolidation, and portfolio streamlining. Restructuring indicates potential budget reallocations and structural openings for managed... | |
| Deploying Q4 growth investments targeting episodic customer conversionManagement made a deliberate strategic commitment to deploy targeted growth capital in Q4 to expand customer acquisition and convert episodic buyers into active, long-term accounts. The investments target private dental practices and emerging DSOs via targeted promotional campaigns and proprietary brand expansion. B2B customer marketing and sales enablement vendors could find opportunities... | |
| Managing COGS inflation through pricing and private label brandsExecutive leadership cited ongoing inflation in cost of goods sold, which is being offset through productivity measures, strategic pricing adjustments, and promoting company-owned lower-cost equivalent products. Inflationary headwinds on commodity materials like rubber and medical consumables represent an active challenge. Suppliers offering cost-effective private-label alternatives or supply... | |
| Macro and election headwinds in Brazil slow implant salesChallenging macroeconomic and political conditions around elections in Brazil created a noticeable regional headwind, dampening implant sales performance within the global specialty products group. This contrasts with positive implant momentum in Europe and the US. Territory planning should account for softened demand and volatility in Latin American healthcare distribution channels. |
Signal API · MCP
Track Henry Schein with the Signal API
One POST /v1/companies/enrich call with henryschein.com returns Henry Schein 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"henryschein.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about Henry Schein 10-Q
When did Henry Schein file its latest 10-Q?
What did Henry Schein disclose in its latest 10-Q?
What did Henry Schein say on its recent earnings calls?
Where can I read Henry Schein's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .